Ananya A. Basu

Biochemistry, Genetics and Molecular BiologyChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation”.

A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.15.557708

N/A

0DataRank · unranked

6 citations

Chenlu Zhang, Isabella A. Riha, Assa Magassa, Felicia Ko, Xiaoyu Zhang +1 more

A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation

Nature Chemical Biology(2024)10.1038/s41589-024-01655-9

N/A

0DataRank · unranked

49 citations

Chenlu Zhang, Isabella A. Riha, Assa Magassa, Miguel Campos, Alana Caldwell +3 more

Quantitative proteomics and applications in covalent ligand discovery

Frontiers in Chemical Biology(2024)10.3389/fchbi.2024.1352676

N/A

0DataRank · unranked

7 citations

Xiaoyu Zhang, Ananya A. Basu

Harnessing the FBXW7 somatic mutant R465C for targeted protein degradation

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.03.626601

N/A

0DataRank · unranked

0 citations

Chenlu Zhang, Milad Rouhimoghadam, Anil Vasudevan, Justin M. Reitsma, Xiaoyu Zhang +1 more